Drug Type Small molecule drug |
Synonyms JNJ 18038683 |
Target |
Action antagonists |
Mechanism 5-HT7 receptor antagonists(Serotonin 7 (5-HT7) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H28ClN3O7 |
InChIKeyDIQZMBPDLFAJLK-UHFFFAOYSA-N |
CAS Registry851376-05-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bipolar Disorder | Phase 2 | United States | 01 Sep 2015 | |
Depressive Disorder | Phase 2 | United States | 01 Sep 2015 | |
Depressive Disorder, Major | Phase 2 | United States | 01 Dec 2007 |
Phase 2 | 60 | (JNJ-18038683) | rqeiudcpir(prjgzbqldg) = ywteesmsfu svloyvoivp (sxxnkvaiiy, 1.31) View more | - | 03 Jul 2023 | ||
Placebo (Placebo) | rqeiudcpir(prjgzbqldg) = qgxqcocfos svloyvoivp (sxxnkvaiiy, 1.33) View more |